(Q38953075)

7 September 2017

title

Triamcinolone acetonide nanoparticles incorporated in thermoreversible gels for age-related macular degeneration (English)

1 reference

7 September 2017

0 references

Anjali Hirani

1

1 reference

7 September 2017

Aditya Grover

2

1 reference

7 September 2017

Yong W Lee

3

1 reference

7 September 2017

Yashwant Pathak

4

1 reference

7 September 2017

Vijaykumar Sutariya

5

1 reference

7 September 2017

publication date

26 September 2014

1 reference

Pharmaceutical Development and Technology

7 September 2017

published in

1 reference

7 September 2017

volume

21

1 reference

7 September 2017

issue

1

1 reference

7 September 2017

page(s)

61-67

1 reference

Use of intravitreal injection of triamcinolone acetonide in the treatment of age-related macular degeneration

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Corticosteroids in ophthalmology: past-present-future

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Inhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Locally administered ocular corticosteroids: benefits and risks

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Current treatment limitations in age-related macular degeneration and future approaches based on cell therapy and tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Treatment of age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

New Approach of Anti-VEGF Agents for Age-Related Macular Degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Model of transient drug diffusion across cornea.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Challenges and obstacles of ocular pharmacokinetics and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Intravitreal injection of therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Ocular drug delivery systems: An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Polymeric triamcinolone acetonide nanoparticles as a new alternative in the treatment of uveitis: in vitro and in vivo studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Ocular disposition, pharmacokinetics, efficacy and safety of nanoparticle-formulated ophthalmic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

PLGA nanoparticles in drug delivery: the state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Brain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Brain-targeted delivery of Tempol-loaded nanoparticles for neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

In situ thermal gelling polypeptide for chondrocytes 3D culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

An anti-angiogenic reverse thermal gel as a drug-delivery system for age-related wet macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Thermoreversible gel for delivery of activin receptor-like kinase 5 inhibitor SB-505124 for glaucoma filtration surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Thermoreversible-mucoadhesive gel for nasal delivery of sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Encapsulation of dexamethasone into biodegradable polymeric nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Tailor-made pentablock copolymer based formulation for sustained ocular delivery of protein therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Novel pentablock copolymer (PLA-PCL-PEG-PCL-PLA) based nanoparticles for controlled drug delivery: Effect of copolymer compositions on the crystallinity of copolymers and in vitro drug release profile from nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Specific uptake of folate-decorated triamcinolone-encapsulating nanoparticles by retinal pigment epithelium cells enhances and prolongs antiangiogenic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

Drug delivery systems for vitreoretinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

RETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2014.965326

10.3109/10837450.2014.965326

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference